NCT05074459View on ClinicalTrials.gov

A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

July 18, 2022

Study Completion Date

July 18, 2022

Conditions
Healthy Participants
Interventions
DRUG

Eptinezumab Mammalian Cell Line

Concentrate for solution for IV infusion

DRUG

Eptinezumab Yeast Cell Line

Concentrate for solution for IV infusion

Trial Locations (2)

32117

Labcorp Clinical Research Unit, Inc., Daytona Beach

53715

Labcorp Clinical Research Unit, Inc., Madison

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT05074459 - A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines | Biotech Hunter | Biotech Hunter